Cargando…
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents
Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419574/ https://www.ncbi.nlm.nih.gov/pubmed/30773430 http://dx.doi.org/10.1016/j.bmcl.2019.01.035 |
_version_ | 1783403973445681152 |
---|---|
author | Francis, Stuart Croft, Daniel Schüttelkopf, Alexander W. Parry, Charles Pugliese, Angelo Cameron, Ken Claydon, Sophie Drysdale, Martin Gardner, Claire Gohlke, Andrea Goodwin, Gillian Gray, Christopher H. Konczal, Jennifer McDonald, Laura Mezna, Mokdad Pannifer, Andrew Paul, Nikki R. Machesky, Laura McKinnon, Heather Bower, Justin |
author_facet | Francis, Stuart Croft, Daniel Schüttelkopf, Alexander W. Parry, Charles Pugliese, Angelo Cameron, Ken Claydon, Sophie Drysdale, Martin Gardner, Claire Gohlke, Andrea Goodwin, Gillian Gray, Christopher H. Konczal, Jennifer McDonald, Laura Mezna, Mokdad Pannifer, Andrew Paul, Nikki R. Machesky, Laura McKinnon, Heather Bower, Justin |
author_sort | Francis, Stuart |
collection | PubMed |
description | Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies. |
format | Online Article Text |
id | pubmed-6419574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier Science Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-64195742019-04-15 Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents Francis, Stuart Croft, Daniel Schüttelkopf, Alexander W. Parry, Charles Pugliese, Angelo Cameron, Ken Claydon, Sophie Drysdale, Martin Gardner, Claire Gohlke, Andrea Goodwin, Gillian Gray, Christopher H. Konczal, Jennifer McDonald, Laura Mezna, Mokdad Pannifer, Andrew Paul, Nikki R. Machesky, Laura McKinnon, Heather Bower, Justin Bioorg Med Chem Lett Article Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies. Elsevier Science Ltd 2019-04-15 /pmc/articles/PMC6419574/ /pubmed/30773430 http://dx.doi.org/10.1016/j.bmcl.2019.01.035 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Francis, Stuart Croft, Daniel Schüttelkopf, Alexander W. Parry, Charles Pugliese, Angelo Cameron, Ken Claydon, Sophie Drysdale, Martin Gardner, Claire Gohlke, Andrea Goodwin, Gillian Gray, Christopher H. Konczal, Jennifer McDonald, Laura Mezna, Mokdad Pannifer, Andrew Paul, Nikki R. Machesky, Laura McKinnon, Heather Bower, Justin Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title | Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title_full | Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title_fullStr | Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title_full_unstemmed | Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title_short | Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
title_sort | structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419574/ https://www.ncbi.nlm.nih.gov/pubmed/30773430 http://dx.doi.org/10.1016/j.bmcl.2019.01.035 |
work_keys_str_mv | AT francisstuart structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT croftdaniel structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT schuttelkopfalexanderw structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT parrycharles structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT puglieseangelo structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT cameronken structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT claydonsophie structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT drysdalemartin structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT gardnerclaire structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT gohlkeandrea structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT goodwingillian structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT graychristopherh structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT konczaljennifer structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT mcdonaldlaura structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT meznamokdad structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT panniferandrew structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT paulnikkir structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT macheskylaura structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT mckinnonheather structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents AT bowerjustin structurebaseddesignsynthesisandbiologicalevaluationofanovelseriesofisoquinoloneandpyrazolo43cpyridineinhibitorsoffascin1aspotentialantimetastaticagents |